Corporate Governance

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including Parkinson’s disease, post-stroke walking difficulty, migraine, and multiple sclerosis. Acorda markets three FDA-approved therapies, including AMPYRA^® (dalfampridine) Extended Release Tablets, 10 mg.

Corporate Governance Guidelines

Download

Acorda Corporate Guidelines 66 KB

Committee Charters

Download

Audit Commitee 29 KB

Compensation Committee 26 KB

Nominations & Governance Committee 33 KB

Compliance Committee 20 KB

Research & Development Committee 197 KB

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.

Chairperson